Dideoxynucleoside resistance emerges with prolonged zidovudine monotherapy. The RV43 Study Group.
Human immunodeficiency virus type 1 (HIV-1) isolates resistant to zidovudine (ZDV) have previously been demonstrated to exhibit in vitro cross-resistance to other similar dideoxynucleoside agents which contain a 3'-azido group. However, cross-resistance to didanosine (ddI) or dideoxycytidine (ddC) h...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1994
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284445/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8192457/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.2.307 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
